<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-13T20:13:00+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>新药大家风云对话，2020中国新药创新者大会圆满落幕！</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/lbQQS1Tqt0CQijZ6cScJSQ</id>
    <link href="https://mp.weixin.qq.com/s/lbQQS1Tqt0CQijZ6cScJSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅升级】药融云数据V2.0版本正式发布，医药数据免费查</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/svVFuthuM8r1JOFnO0SDag</id>
    <link href="https://mp.weixin.qq.com/s/svVFuthuM8r1JOFnO0SDag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】药明康德业务和投资双驱动，疫情下保持高增长；药石科技-收入快速恢复，砌块龙头成长趋势不变...</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/qygIx0AXPMdI3p5i55vpow</id>
    <link href="https://mp.weixin.qq.com/s/qygIx0AXPMdI3p5i55vpow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【温江行收官】一流企业四川科伦、药明康德引药融圈企业家考察团成员频频点赞</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Wc_qkf0Opqwatkt5ONRn4A</id>
    <link href="https://mp.weixin.qq.com/s/Wc_qkf0Opqwatkt5ONRn4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11家，广西第一批化工园区公布（附6省已认定名单）</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/sDfSci0Bld_tU505uk3-KQ</id>
    <link href="https://mp.weixin.qq.com/s/sDfSci0Bld_tU505uk3-KQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖CD38抗体HLX15提交临床申请，研发投入约1511万元</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Hv5syBQOFVnihqc95fOaSg</id>
    <link href="https://mp.weixin.qq.com/s/Hv5syBQOFVnihqc95fOaSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四川科伦药业2注射液通过（含视同）一致性评价</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Trl3P3Bxdp1LlSqdTxrbAQ</id>
    <link href="https://mp.weixin.qq.com/s/Trl3P3Bxdp1LlSqdTxrbAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大咖云集，千人共聚，中国新药创新者大会再掀热潮！明日精彩继续</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/gcHVcmAx37R00tQXO02tuw</id>
    <link href="https://mp.weixin.qq.com/s/gcHVcmAx37R00tQXO02tuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！费米子科技完成A轮融资，累计融资额上亿元</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/xy7Jx2mlB4QzmZveifoKgw</id>
    <link href="https://mp.weixin.qq.com/s/xy7Jx2mlB4QzmZveifoKgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大咖云集，千人共聚，中国新药创新者大会再掀热潮！明日精彩继续</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/9E7N7WoEaU3FoN0ws783iA</id>
    <link href="https://mp.weixin.qq.com/s/9E7N7WoEaU3FoN0ws783iA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】华大基因新冠检测试剂需求持续旺盛，常规业务逐步恢复；复星医药净利润增速远超营收，产品管线逐步丰富...</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/8NcuxR7A6CnHchp7PjAz2g</id>
    <link href="https://mp.weixin.qq.com/s/8NcuxR7A6CnHchp7PjAz2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴：泊马度胺胶囊重磅获批，多发性骨髓瘤重磅药！11月12日45个批件待领取</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/zCNTxAuO6_XJLHtRWQKpog</id>
    <link href="https://mp.weixin.qq.com/s/zCNTxAuO6_XJLHtRWQKpog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成都赜灵生物引进5款创新药，NLRP3抑制剂、RIP1/2抑制剂等值得关注</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/iTsLCu1_2yv16HGxghiZtg</id>
    <link href="https://mp.weixin.qq.com/s/iTsLCu1_2yv16HGxghiZtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国首款湿疹新药,辉瑞Crisaborole售价来袭！</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/L1tPIjrnVcxZKtR3cTjRWw</id>
    <link href="https://mp.weixin.qq.com/s/L1tPIjrnVcxZKtR3cTjRWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昭衍新药：在手订单17亿+，将成为第4家A+H的CRO</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/rWZg3YTSM_h5LzYr3NsI-w</id>
    <link href="https://mp.weixin.qq.com/s/rWZg3YTSM_h5LzYr3NsI-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【就在明天，成都】2020中国新药创新者大会-药物发现到临床的攀珠峰之旅</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/X51snH6m51iRgjuEk6726g</id>
    <link href="https://mp.weixin.qq.com/s/X51snH6m51iRgjuEk6726g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晶泰科技：拥抱人工智能，开启药物研发快进模式</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/2nJSUuFPXhGQ7UW2pE6GEg</id>
    <link href="https://mp.weixin.qq.com/s/2nJSUuFPXhGQ7UW2pE6GEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>未来已来——特应性皮炎领域深度梳理</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/l4Oq_1qVY9_A3p9EDuWMpQ</id>
    <link href="https://mp.weixin.qq.com/s/l4Oq_1qVY9_A3p9EDuWMpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】健友股份再获阿扎胞苷ANDA，海外制剂放量可期；先导收购vernalis加速全球化..</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/Y0LNce-xnDDf0DbQ2hn-dA</id>
    <link href="https://mp.weixin.qq.com/s/Y0LNce-xnDDf0DbQ2hn-dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>派克生物-一站式生命科学解决方案供应商</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/JFqijmT9auF2JyhDALMxDA</id>
    <link href="https://mp.weixin.qq.com/s/JFqijmT9auF2JyhDALMxDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>